Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin

Exclusion Criteria

• •Known bleeding disorder
• •History of epilepsy or on anti-seizure medication
• •Uncontrolled hypertension or diabetes
• •Uncontrolled IOP
• •Eye pathology leading to inaccurate IOP measurement
• •Visually significant retinal pathology affecting vision in past or active (such as diabetic retinopathy or age related macular degeneration)
• •Non-glaucomatous optic neuropathy
• •Visually significant cataract (worse then 2+ cataract, or what is determined visually clinically significant by physician)
• •History of ocular trauma
• •Selective laser trabeculoplasty or laser procedure within past 3 months
• •Cataract surgery within past 3 months
• •Incisional glaucoma surgery within 6 months
• •Current use of nitroglycerin
• •Current use of antiplatelet therapy besides aspirin (such as clopidogrel) or anticoagulation (such as warfarin)
• •Current use of systemic steroids or immunomodulating agents such as methotrexate.
• •Sensitivity or allergy to any ingredients in GlaucoCetin: Curcumin, L-Taurine, N-Acetyl Cysteine, Niacinamide, Ginkgo Biloba, Lipoic Acid, Citicoline, Grape Seed Extract, Green Tea Leaf Extract, Coenzyme Q10, Biotin, Natural Astaxanthin, flavonoid complex containing Fisetin, Quercetin, and Luteolin
• •Recent change in systemic medications or vitamins
• •Use of Biotin, Ginkgo Biloba, Citicoline within past 3 months (or any other Glaucocetin ingredients within 1 month)
• •Unreliable visual fields
• •Unwilling to take supplement or placebo for 6 months